User fee reauthorization bill advances in the House, Senate eyes different riders

Regulatory NewsRegulatory NewsAPIsAudit/FDA InspectionBiologicsBiotechnologyClinical TrialsCombination ProductsComplianceDiagnosticsEthicsMedical DevicesNorth AmericaOTCOtherPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development